ID18059A - Senyawa aktif optik - Google Patents

Senyawa aktif optik

Info

Publication number
ID18059A
ID18059A IDP972913A ID972913A ID18059A ID 18059 A ID18059 A ID 18059A ID P972913 A IDP972913 A ID P972913A ID 972913 A ID972913 A ID 972913A ID 18059 A ID18059 A ID 18059A
Authority
ID
Indonesia
Prior art keywords
active compounds
optical active
optical
compounds
active
Prior art date
Application number
IDP972913A
Other languages
English (en)
Inventor
Marc Dr Gerspacher
Andreas Von Dr Sprecher
Robert Dr Mah
Silvio Dr Roggo
Stefan Stutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID18059A publication Critical patent/ID18059A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDP972913A 1996-08-22 1997-08-20 Senyawa aktif optik ID18059A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH206196 1996-08-22

Publications (1)

Publication Number Publication Date
ID18059A true ID18059A (id) 1998-02-26

Family

ID=4225003

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972913A ID18059A (id) 1996-08-22 1997-08-20 Senyawa aktif optik

Country Status (32)

Country Link
US (1) US6319917B1 (id)
EP (1) EP0923550B1 (id)
JP (1) JP3654908B2 (id)
KR (1) KR100467402B1 (id)
CN (1) CN1119328C (id)
AR (1) AR009266A1 (id)
AT (1) ATE224875T1 (id)
AU (1) AU721850B2 (id)
BR (1) BR9711350A (id)
CA (1) CA2264065C (id)
CO (1) CO4900047A1 (id)
CZ (1) CZ294233B6 (id)
DE (1) DE69715886T2 (id)
DK (1) DK0923550T3 (id)
ES (1) ES2184083T3 (id)
HK (1) HK1021372A1 (id)
HU (1) HU226395B1 (id)
ID (1) ID18059A (id)
IL (1) IL128631A (id)
MY (1) MY132550A (id)
NO (1) NO312292B1 (id)
NZ (1) NZ334736A (id)
PE (1) PE107498A1 (id)
PL (1) PL193731B1 (id)
PT (1) PT923550E (id)
RU (1) RU2185375C2 (id)
SI (1) SI0923550T1 (id)
SK (1) SK283991B6 (id)
TR (1) TR199900363T2 (id)
TW (1) TW438777B (id)
WO (1) WO1998007694A1 (id)
ZA (1) ZA977493B (id)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281300B1 (en) * 1998-03-20 2001-08-28 Exxon Chemical Patents, Inc. Continuous slurry polymerization volatile removal
GB0010958D0 (en) * 2000-05-05 2000-06-28 Novartis Ag Organic compounds
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
GB0224788D0 (en) * 2002-10-24 2002-12-04 Novartis Ag Organic compounds
GB2394417A (en) * 2002-10-24 2004-04-28 Novartis Ag Solid dispersion comprising a piperidine substance P antagonist and a carrier
JP2007509184A (ja) * 2003-10-27 2007-04-12 ノバルティス アクチエンゲゼルシャフト 尿失禁の処置におけるニューロキニンアンタゴニストの使用
PL1691814T3 (pl) * 2003-12-01 2012-12-31 Cambridge Entpr Ltd Środki przeciwzapalne
GB0402679D0 (en) * 2004-02-06 2004-03-10 Novartis Ag Organic compounds
GB0607532D0 (en) * 2006-04-13 2006-05-24 Novartis Ag Organic compounds
JO2630B1 (en) * 2006-04-13 2012-06-17 نوفارتيس ايه جي Organic compounds
EP1938804A1 (en) * 2006-12-22 2008-07-02 Novartis AG Pharmaceutical formulation comprising neurokinin antagonist
EA200970706A1 (ru) 2007-01-24 2010-02-26 Глэксо Груп Лимитед Новые фармацевтические композиции
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
MX2011008878A (es) * 2009-02-24 2011-09-21 Novartis Ag Usos de antagonistas de los receptores de nk.
RU2697414C1 (ru) * 2018-05-11 2019-08-14 Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" Новый антагонист тахикининовых рецепторов и его применение

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06509087A (ja) 1991-07-05 1994-10-13 メルク シヤープ エンド ドーム リミテツド 芳香族化合物、それらを含む医薬組成物、及び治療におけるそれらの使用
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
US5217996A (en) 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
EP0716077A1 (de) * 1994-12-08 1996-06-12 Ciba-Geigy Ag Aromatisch substituierte Omega-Aminoalkansäureamide und Alkansäurediamide und ihre Verwendung als Renininhibitoren
TR199700834T1 (xx) * 1995-02-22 1998-01-21 Novartis Ag 1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�.

Also Published As

Publication number Publication date
HU226395B1 (en) 2008-11-28
JP2001503387A (ja) 2001-03-13
BR9711350A (pt) 1999-08-17
DE69715886T2 (de) 2003-05-15
WO1998007694A1 (en) 1998-02-26
DE69715886D1 (de) 2002-10-31
NZ334736A (en) 2000-09-29
AR009266A1 (es) 2000-04-12
SK283991B6 (sk) 2004-07-07
ZA977493B (en) 1998-08-03
CN1233238A (zh) 1999-10-27
NO990786L (no) 1999-03-25
TW438777B (en) 2001-06-07
SI0923550T1 (en) 2003-02-28
CA2264065A1 (en) 1998-02-26
CZ58199A3 (cs) 1999-06-16
CO4900047A1 (es) 2000-03-27
HK1021372A1 (en) 2000-06-09
AU721850B2 (en) 2000-07-13
HUP0001165A3 (en) 2002-02-28
MY132550A (en) 2007-10-31
DK0923550T3 (da) 2003-01-06
ES2184083T3 (es) 2003-04-01
SK22199A3 (en) 2000-02-14
HUP0001165A2 (hu) 2000-11-28
RU2185375C2 (ru) 2002-07-20
TR199900363T2 (xx) 1999-04-21
EP0923550B1 (en) 2002-09-25
AU4299397A (en) 1998-03-06
PT923550E (pt) 2003-01-31
JP3654908B2 (ja) 2005-06-02
ATE224875T1 (de) 2002-10-15
EP0923550A1 (en) 1999-06-23
PL193731B1 (pl) 2007-03-30
NO312292B1 (no) 2002-04-22
PL331740A1 (en) 1999-08-02
CZ294233B6 (cs) 2004-11-10
KR20000068325A (ko) 2000-11-25
CN1119328C (zh) 2003-08-27
US6319917B1 (en) 2001-11-20
PE107498A1 (es) 1999-01-28
IL128631A (en) 2002-09-12
KR100467402B1 (ko) 2005-01-24
CA2264065C (en) 2008-02-05
IL128631A0 (en) 2000-01-31
NO990786D0 (no) 1999-02-19

Similar Documents

Publication Publication Date Title
ID16578A (id) Piringan optik
ID21646A (id) Piringan optik
ID22683A (id) Pengatur serat optik
DE69835466D1 (de) Optischer Verstärker
ID18680A (id) Disket optik
ID16057A (id) Pengatur atau penyusun serat optik
PT989130E (pt) Trifluorometilalquilmino-triazolopirimidinas fingicidas opticamente activas
DE69722386D1 (de) Optischer körper
DE69716789D1 (de) Brillenglas
DE69941102D1 (de) Optischer Verstärker
ID19963A (id) Pesawat penggerak piringan optik
DE69805048D1 (de) Photodiode
DE69704544T2 (de) Optischer Halbleiterverstärker
ID21953A (id) Pikap optik
DE59807663D1 (de) Endoskopobjektiv
NO983853D0 (no) Optisk forbindelse
ID18059A (id) Senyawa aktif optik
DE69938710D1 (de) Optischer verstärker
ID19752A (id) Serat optik moda-tunggal
DE69714248T2 (de) Optischer isolator
DE69703678T2 (de) Optischer halbleiterverstärker
DE59702841D1 (de) Endoskopoptik
DE69730384D1 (de) Optisches Bauelement
NO20005271D0 (no) Optisk aktive tetrahydrobenzindol-derivater
DE59900752D1 (de) Optischer neigungsmesser